€26.72
0.30% yesterday
Amsterdam, Nov 27, 05:36 pm CET
ISIN
BE0003818359
Symbol
GLPG

Galapagos Stock price

€26.72
-0.32 1.18% 1M
+1.08 4.21% 6M
+0.20 0.75% YTD
+0.26 0.98% 1Y
-12.43 31.75% 3Y
-78.38 74.58% 5Y
-19.88 42.66% 10Y
+18.22 214.35% 20Y
Amsterdam, Closing price Thu, Nov 27 2025
+0.08 0.30%
ISIN
BE0003818359
Symbol
GLPG
Industry

Key metrics

Basic
Market capitalization
€1.8b
Enterprise Value
€-1.3b
Net debt
positive
Cash
€3.1b
Shares outstanding
66.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
6.1 | 6.3
EV/Sales
negative | negative
EV/FCF
4.5
P/B
0.7
Financial Health
Equity Ratio
70.0%
Return on Equity
2.6%
ROCE
-10.2%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
€286.8m | €280.5m
EBITDA
- | €-209.8m
EBIT
€-320.0m | €-227.8m
Net Income
€-436.0m | €-182.0m
Free Cash Flow
€-287.0m
Growth (TTM | estimate)
Revenue
-43.1% | 1.8%
EBITDA
- | -101.7%
EBIT
-49.8% | -48.9%
Net Income
-267.1% | -345.9%
Free Cash Flow
30.3%
Margin (TTM | estimate)
Gross
84.1%
EBITDA
- | -74.8%
EBIT
-111.6%
Net
-152.0% | -64.9%
Free Cash Flow
-100.1%
More
EPS
€-6.6
FCF per Share
€-4.3
Short interest
-
Employees
704
Rev per Employee
€390.0k
Show more

Is Galapagos a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Galapagos Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Galapagos forecast:

2x Buy
12%
5x Hold
29%
10x Sell
59%

Analyst Opinions

17 Analysts have issued a Galapagos forecast:

Buy
12%
Hold
29%
Sell
59%

Financial data from Galapagos

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
287 287
43% 43%
100%
- Direct Costs 46 46
139% 139%
16%
241 241
22% 22%
84%
- Selling and Administrative Expenses 151 151
19% 19%
53%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -320 -320
50% 50%
-112%
Net Profit -436 -436
267% 267%
-152%

In millions EUR.

Don't miss a Thing! We will send you all news about Galapagos directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galapagos Stock News

Neutral
GlobeNewsWire
2 days ago
Mechelen, Belgium ; November 26, 2025, 07:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
Neutral
Seeking Alpha
21 days ago
Galapagos NV ( GLPG ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Glenn Schulman Henry Gosebruch - CEO & Executive Director Aaron Cox - Chief Financial Officer Dan Grossman - Chief Strategy Officer Conference Call Participants Faisal Khurshid - Leerink Partners LLC, Research Division Brian Abrahams - RBC Capital Markets, Research Division Philip Nadeau - TD Cowen, Re...
Neutral
GlobeNewsWire
24 days ago
Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma
More Galapagos News

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Head office Belgium
CEO Henry Gosebruch
Employees 704
Founded 1999
Website www.glpg.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today